![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Wednesday, February 17, 2021 12:55:19 PM
Rushnet Inc. (OTC:RSHN)
1001 Grand Ave. Suite 207 / Glenwood Springs, CO 81602 / Phone: 321-266-6895
Website: https://rushnetinc.com/
Twitter: @GetRushnet / https://twitter.com/GetRushnet
CEO - Frank DeAngelo / LinkedIn https://www.linkedin.com/in/frank-deangelo-b8058210/ / ZoomInfo https://www.zoominfo.com/p/Frank-Deangelo/1242230077
Frank Deangelo is the Chief Executive Officer of RushNet, Inc. Mr. Deangelo is the retired President and CEO of Applejam, Inc. which was one of the world’s largest restaurant franchises which he grew to having over $120,000,000 in sales with over 2500 employees before selling it.
Chairman of the Board, Chief Medical Officer - Dr. Richard Goulding, M.D.
Dr. Richard E. Goulding, MD, is Chairman, Chief Medical Officer at RushNet, Inc., a Chairman & Chief Medical Officer at Gold River Productions, Inc., a Chairman, President & Chief Executive Officer at Real American Capital Corp., a Medical Director at Physhield, a Member at American Academy of Facial & Plastic Reconstruction Surgery, a Member at American Academy of Otolaryngic Allergy, a Member at American Academy of Otolaryngology-Head & Neck Surgery, Inc., a Member at American Medical Association and a Member at Florida Society of Otolaryngology. He is on the Board of Directors at Phyhealth Underwriters, Inc. Dr. Goulding was previously employed as a Secretary & Director by Physicians Healthcare Management Group, Inc. and a Secretary & Director by Phyhealth Corp. He received his undergraduate degree from the University of Florida and a doctorate degree from Loyola University Maryland, Inc.. (from Wall Street Journal-link)
Contacts:
Company Phone: (321) 266-6895 (RG)
fda69@yahoo.com (from OTC website for company e-mail address) FDA = Frank DeAngelo?
support@rushnetinc.com (contact e-mail from RSHN press releases)
Transfer Agent: Mountain Share Transfer, (303)-460-1149
OTC Company Description (as of 2/16/21)
Rushnet has historical ties to the beverage industry and while this will be a focus with the development of its trademarked "Knockout PunchTM" products line, Rushnet will develop and manufacture products from the underserved areas and sectors of CBD production. Full spectrum, nanotized CBD will be an important component of Knockout PunchTM's three beverage lines. Focusing on edibles and acquiring companies with significant financial future, Rushnet has associates in the medical, nutraceutical, cultivation and logistics industries. With a focus on health, wellness, the heart of RSHN is products that are fun, healthy and will improve the quality of life. Having financed a noted lobbyist to secure a number of government grants, RSHN is poised for the future.
Standard Press Release Company Description
Dedicated to changing people's lives, Rushnet is a groundbreaking company aiming at improving quality of life and longevity. Our broad products and trademarked brand Herbal Therapeutics include nutraceuticals, CBD, land, education and more. With a unique staff of physicians, cultivators, and CBD experts, we are poised to tackle different disease states on an unprecedented level. Utilizing years of experience in herbals, rare cannabinoids, traditional and non-traditional methods of patient care, we are in the unique position to utilize CBD and herbals in the most effective ways possible. Emphasis on what already works, then augmenting effective formulas with high-quality cannabinoids in therapeutic levels can achieve unprecedented symptom control in a myriad of disease states.
Share Structure
Authorized Shares: 9,000,000,000
Outstanding Shares: 7,764,641,795 - as of 2/16/21
NO DILUTION SINCE RG TOOK OVER RSHN
All Past Financials & Current Status
*All financials since RG took over the ticker are available on OTC. Also listed below are what is due in order to become current
Annual Report, Ended 12/31/20 - Due 4/29/21
Attorney Letter to bring Current - Past Due
Quarterly Report, Ended 9/30/20 - Past Due
Quarterly Report, Ended 6/30/20 - Past Due
Quarterly Report, Ended 3/31/20 - Past Due
Annual Report, Ended 12/31/19 - Past Due
Quarterly Report, Ended 9/30/19 - Posted 11/19/19
Quarterly Report, Ended 6/30/19 - Posted 9/12/19
Quarterly Report, Ended 3/31/19 - Posted 5/20/19
Annual Report, Ended 12/31/18 - Posted 4/1/19
Annual Financials, Ended 12/31/18 - Posted 4/1/19
Quarterly Report, Ended 9/30/18 - Posted 11/15/18
Quarterly Report, Ended 6/30/18 - Posted 7/30/18
https://www.otcmarkets.com/stock/RSHN/disclosure
Other Links
Colorado Secretary of State Filings for RushNet, Inc. (search “Rushnet”)
https://www.sos.state.co.us/biz/BusinessEntityCriteriaExt.do?resetTransTyp=Y
OTC Markets: RSHN https://www.otcmarkets.com/stock/RSHN/overview
Products In Development or previously mentioned:
Knockout Punch (™)
Knockout Punch™ comes in a small vial and is used before or after participating in any physical activity that may result with a blow to the head. Made from high quality organically grown CBD.
Knockout Punch (™) Sleed Aid
The combination of CBD and melatonin in Knockout Punch™ has also been shown to aid in a deep, restful, recovery sleep. Knockout Punch™ for sleep will involve several propietary ingredients and techniques making a perfect and better alternative to what is currently on the market for sleep aid.
KO Punch
Details not mentioned
SobriPlex CBD (no updates in some time, was related to Rooshine, Inc. news)
Proprietary formulation developed by Dr. Goulding and Bruce Bond, DC - which, among other benefits, is designed to alleviate some of the adverse effects of alcohol consumption, including the minimization of a hangover and the minimization of brain cell depletion.
Herbal Therapeutics - Potential Brand Name being trademarked by GRPS
2 Trademarks
KO PUNCH Trademark (Serial No. 88101358)
Active http://tsdr.uspto.gov/#caseNumber=88101358&caseSearchType=US_APPLICATION&caseType=DEFAULT&searchType=statusSearch
KO Trademark (Serial No. 88101335)
Active http://tsdr.uspto.gov/#caseNumber=88101335&caseType=SERIAL_NO&searchType=statusSearch
**A & E Water trademarks are dead, therefore unlikely these products will be launched.
Joint Ventures:
Gold River Production Services, Inc.(GRPS)
Website: www.grpsinc.com /
Twitter: @grpsinc
Dr. Bruce Bond, DC, DCABN
Dr. Bond practiced for twenty-two years in Cleveland Ohio where he started and ran a successful Functional Wellness and chiropractic clinic. He currently works with his son in Florida at his son’s clinic in Melbourne, Florida. The Florida clinic was started in a town in which he and his son were not known and in three years is a successful profitable private pay clinic utilizing effective herbal and nutritional therapies. Dr. Bond is on a mission because he sees people are losing life to their years and living in bodies shattered by time. His clinical experience has shown him that by utilizing effective gentle botanicals that the human body can restore form and function. Dr. Bond has been bringing his clinical practical experience, humor and empowering style to clinicians for over seventeen years. His unique style of making the complicated simple will enable you to go back on Monday and help those who want to restore and revitalize themselves both physically and emotionally. (Link)
Our synergistic business model (RushNet and GRPS) includes acquiring private companies to become a subsidiary. It also includes, as an alternative to an acquisition, creating a strategic alliance with companies which could bring greater value to each RushNet and GRPS and its subsidiaries. We offer unique advantages to each participant in a joint venture type or parent-subsidiary. (See this link https://www.otcmarkets.com/stock/RSHN/news/RushNet-Inc-RSHN-And-XYZ-Hemp-Inc-GRPS-Provide-Annual-Update-Concerning-Progress-and-Their-Future?id=216442)
Premier BioMedical, Inc. (BIEI) / Halberd Corpoation (HALB) Joint Venture
Website: http://www.premierbiomedical.com/
Twitter: https://twitter.com/premierbiomedic?lang=en
Premier Biomedical, Inc. has acquired exclusive licenses for patent-pending medications/medical procedures to develop cures for a significant number of the most debilitating and often fatal illnesses affecting mankind: Amyotrophic Lateral Sclerosis (ALS), Traumatic Brain Injury (TBI), Multiple Sclerosis (MS), Clinical Depression, Alzheimer’s Disease, Blood Sepsis, Atherosclerosis and Cancer. We have developed an aggressive timetable to advance the development of these breakthrough technologies through laboratory, hospital, and clinical trials. We have initiated the development of potential patient trial application lists. We have a management team with extensive experience and contacts in the medical/pharmaceutical fields as well as a demonstrated track record of launching new business ventures in a competitive environment. Our extensive contacts in the medical/pharmaceutical industries will ensure that new developments will achieve maximum visibility and exposure to the market. Transparency and accountability will continue to be ensured via regular issuance of technical progress reports, financials, and investor relations reports to maintain investor enthusiasm.
Premier Biomedical, Inc., a Nevada corporation, is a fully reporting issuer under the Securities Exchange Act of 1934, listed under “BIEI” on the OTC-BB Index.
About the Joint Venture:
On July 30, 2019, an agreement was signed forming a joint venture with New Earth Development Corporation, RushNet, Inc., and XYZ Hemp, Inc. (AKA GRPS) to manufacture, market and sell a revolutionary Anti-Addiction Patch containing Premier Biomedicals patented natural and synthetic formulation. The product will be based on the topical pain relieving patch technology currently marketed by Premier Biomedical. Because of the current focus on the opioid drug overdose epidemic, not only in the United States, but worldwide, the joint venture will quickly seek to expand sales globally.
Interview : https://www.youtube.com/watch?v=Ifm1YchizKM
For more information please contact:
William A. Hartman
President and CEO
Premier Biomedical Inc.
(814) 786-8849
w.hartman@premierbiomedical.com
Other Things to Note:
-GRPS & RSHN sold New Earth to STNT and RSHN received 250,000 shares.
-RSHN had 3 grant proposals that were related to Great Rate Freight. The rest of the grant proposals were related to GRPS primarily. Grants are unlikely at this point, especially for the benefit of RSHN.
-Product Placement Unlimited was engaged jointly by RSHN and GRPS to place products.
If a logistics operation is pursued, it will be under a different name than GRF due to a falling out with the owner CB (as stated in the Q&A videos)
-RSHN & GRPS will be launching products with interactive how-to-videos that tell the patient how to use the products and for what benefit. (as stated in the Q&A video and last press release)
THERE IS SO MUCH DD I can't possibly keep track of it all, but I do.
Many things no longer at play here IMO
LeGanja Fairy - contract is now in question per last GRPS financials
Marakata
Bella Buds
HempHub
Great Rate Freight
No word on whether Dr. Miller and the nanotechnology is still in play.
etc etc.
Stick to the stuff that is verifiable and we still have a winner here.
Go $RSHN
Element79 Gold Corp Appoints Warren Levy to Board of Directors • ELMGF • Aug 28, 2024 9:51 AM
Integrated Ventures Announces Strategic Entry Into Health & Wellness Industry with Focus on GLP-1 Products • INTV • Aug 28, 2024 8:30 AM
ELEMENT79 ANNOUNCES UPLISTING TO OTCQB VENTURE MARKET • ELMGF • Aug 26, 2024 10:03 AM
North Bay Resources Announces Gold Assays up to 2.2 Ounces per Ton, Fran Gold Project, British Columbia • NBRI • Aug 26, 2024 10:00 AM
PickleJar Unveils Latest Venue Managed Services Innovations in Upcoming Webinar • PKLE • Aug 23, 2024 1:11 PM
Element79 Gold Corp Provides Update on Nevada Portfolio • ELMGF • Aug 23, 2024 8:00 AM